… articles and authors below:   Manufacturing of primary CAR-NK cells in an automated system for the treatment of … Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy Pere Barba et al   Trends in utilization of …

… cell transplantation D. Plan for anti-CD19 directed CAR-T cell therapy Expert Perspective by Professors Blaise and … DLBCL Patients Achieving Only a PET+ PR Appropriate in the CAR-T cell Era? Blood 2020. e-pub ahead of print 2020/10/30; …

… for the past 8 years. With the recent introduction of CAR-T cell therapy and other targeted cellular therapies, a new … outcome following hematopoietic cell transplantation or CAR-T therapy. In the IDWP we believe that our collaborative …

… expanding field Immune effector cell therapies — including CAR-T cells, CAR-NK cells, tumour-infiltrating lymphocytes (TILs), and …

… have been considered, based on emerging evidence from the CAR T-cell and GI-GvHD literature. Expert Perspective by Severine … colitis (IEC-colitis) is an emerging late complication of CAR T-cell therapy, distinct from the well-defined acute …

… focusing on the nursing care for patients receiving CAR-T and bi-specifics therapies. With our full stomach, two …

… in patients following stem cell transplantation and CAR-T therapy. IDWP EBMT continues to lead the scientific, …

… a 3-day meeting dedicated to plasma cell disorders and CAR-T in PC disorders alongside the Cellular Therapy and …

… Claire is Clinical research fellow in Paediatric BMT, CAR-T and Stem Cell Gene Therapy, Manchester University NHS …

… that you work in?   A: Currently, I am a transplant and CAR-T physician at the University Hospital in Zurich, where one … unlikely that targeting just one graft cell type (such as T cells or B cells) would be able to resolve established …